Self-sampling to improve cervical cancer screening attendance

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of self-sampling and HPV testing to increase cervical cancer screening participation among under-screened women in the Czech Republic. It will compare three methods of providing self-sampling devices: by mail, through gynecologists, and via general practitioners. The study aims to determine the acceptability of self-sampling and its impact on screening attendance, while also analyzing sociodemographic factors. The goal is to address the low participation rates in cervical cancer screening and improve women's health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women with age 30-65 years; for arm A women \> 65 years are allowed
* Women live in the Czech Republic.
* Women who have not participate in cervical cancer screening program in the Czech Republic for at least 3 years (Arm B and C).
* Women with completed informed consent.
* Women capable of self-sampling of cervicovaginal swab.

Exclusion Criteria:

* Pregnant women.
* Women with no sexual intercourse experience.
* Women after hysterectomy including cervix.

Where it's running

• University Hospital Olomouc
  Olomouc, Czechia Recruiting

Study contacts

• Study coordinator: Marian Hajduch, MD, PhD.
• Email: marian.hajduch@upol.cz
• Phone: +420 585 632 083

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using liquid biopsies to monitor treatment in HPV-related cancers

  This study tests if using liquid biopsies can help track treatment progress and detect any return of HPV-related cancers, like cervical and throat cancer, in patients.

  Recruiting The Institute of Molecular and Translational Medicine, Czech Republic · Olomouc · NCT05774561

• Blood test for detecting HPV-related gynecologic cancers

  This study is testing a blood test that looks for HPV-related cancer DNA in women with serious cervical issues to see if it can help detect and monitor these cancers without needing invasive procedures.

  Recruiting Northwell Health · New York, New York · NCT05606133

• Detecting gynecologic cancers using DNA markers in vaginal fluid and blood

  This study is testing a new way to detect endometrial, ovarian, and cervical cancers early by looking for specific DNA markers in the vaginal fluid and blood of women with abnormal bleeding.

  Recruiting at 21 sites Mayo Clinic · Phoenix, Arizona and 24 other locations · NCT05051722

• Screening for anal cancer in women with vulvar lesions

  This study is testing if screening for anal cancer with Pap smears can help women over 40 who have vulvar lesions catch any problems early and improve their health.

  Recruiting Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT03061435

• Cervical screening and care options for women living with HIV who test positive for high-risk HPV

  This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.

  Recruiting University of California, San Diego · Nairobi · NCT07925307

• Lived experiences of women with HPV infection

  This study talks with women who have HPV to hear in their own words how the infection affects daily life, relationships, and what information or support they wish they had.

  Recruiting Bilecik Seyh Edebali Universitesi · Bilecik, Bilecik · NCT07920666

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.